Strategic Partnership for AI-Powered Drug Discovery & Design

ModelMole is actively seeking strategic partnerships to revolutionize the drug design pipeline.

Traditional drug discovery is time-consuming and capital-intensive. By integrating state-of-the-art artificial intelligence and advanced computational approaches, we help partners significantly accelerate target identification, lead optimization, and predictive modeling for efficacy and toxicity.

What we bring to the partnership:

• AI-Driven Computational Biology: Proprietary machine learning workflows designed to analyze complex biological datasets and identify novel therapeutic candidates.

• Tech-Forward Mindset: An entrepreneurial approach to R&D, heavily informed by Dr. Guo's experience founding ANGENOVO AS, ensuring solutions are innovative, scalable, and commercially viable.

• De-risked Development: Advanced predictive modeling to fail fast in silicon and succeed in the clinic.

Who we are looking for: We are looking to collaborate with forward-thinking pharmaceutical companies, specialized biotech startups, and innovative academic institutions. Whether you have promising biological targets that require computational validation and drug design, or you are looking to co-develop novel therapeutics from the ground up, we want to hear from you.

Let's collaborate to drive biotech innovation and build next-generation therapeutics together.